iBio, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell iBio, Inc. and other ETFs, options, and stocks.About IBIO
iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets.
CEOMartin B. Brenner
CEOMartin B. Brenner
Employees20
Employees20
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1993
Founded1993
Employees20
Employees20
IBIO Key Statistics
Market cap15.77M
Market cap15.77M
Price-Earnings ratio-0.46
Price-Earnings ratio-0.46
Dividend yield—
Dividend yield—
Average volume369.21K
Average volume369.21K
High today$0.8198
High today$0.8198
Low today$0.78
Low today$0.78
Open price$0.78
Open price$0.78
Volume177.59K
Volume177.59K
52 Week high$6.89
52 Week high$6.89
52 Week low$0.5562
52 Week low$0.5562
People also own
Based on the portfolios of people who own IBIO. This list is generated using Robinhood data, and it’s not a recommendation.